We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
Topics Covered
- Cellular localization
- Nuclear receptor dimerization
- DNA interaction
- RXR heterodimers
- Crosstalk in nuclear receptor dimers
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Merk, D. (2025, May 29). Mechanisms and molecular function of nuclear receptors 1 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved June 1, 2025, from https://doi.org/10.69645/RMSE4385.Export Citation (RIS)
Publication History
- Published on May 29, 2025
Financial Disclosures
- Prof. Dr. Daniel Merk has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Mechanisms and molecular function of nuclear receptors 1
Published on May 29, 2025
7 min
Other Talks in the Series: Nuclear Receptors as Common Therapeutic Targets
Transcript
Please wait while the transcript is being prepared...
0:00
Welcome everyone to Chapter 4 of
this short talk series on
nuclear receptors as
therapeutic targets.
In Chapter 4 and the
consecutive Chapter 5,
we will have a look
at the structural and
the molecular mechanisms of
nuclear receptor activity,
and we will start in Chapter
4 with the mechanisms of
DNA interaction and the
role of dimerization.
0:26
In Chapter 2, we have seen
the classification
of nuclear receptors
based on their
cellular localization
and their dimerization.
Remember that the steroid
hormone receptors of
the NR3 family here
on the left are
Type I nuclear receptors
and are localized in
the cytosol, bound to
heat shock proteins in
the absence of a ligand.
Upon agonist binding,
the receptor dissociates
from the heat shock protein,
forms a homodimer,
and translocates to the
nucleus to bind to the DNA.
The other nuclear receptors
belonging to the Type II,
III, and IV, in contrast,
are typically localized
in the nucleus
and bound to DNA also in
the absence of ligands.
They act in different
mono or oligomeric forms,
depending on what type they
are, and they often form
heterodimers with RXR or
homodimers or monomers.
It should be noted that
several nuclear receptors
of this Type II, III, and IV
can act in more than one of
these forms, so the association
to Type II, III, and IV
is not always exact.
1:35
Here you see an overview of
the nuclear receptor family
with the receptors
labeled according to
their DNA interaction
classification
as Type I, II, III, or IV.
Only steroid hormone
receptors in
the middle and labeled in
violet belong to Class I,
which translocate to the
nucleus after ligand binding,
and then act as homodimers.
The majority of
nuclear receptors
in the NR1 family on the left,
mainly act as heterodimers
with a retinoid X receptor,
abbreviated as RXR,
and they are labeled in blue,
and some of them can
additionally act as a monomer.
revERB receptors and retinoic
acid receptor-related
orphan receptors
also belonging to
the NR1 family on the
left and labeled in red,
typically act as
monomers or homodimers.
The NR2 and NR4 families,
labeled orange,
can be active in all
three forms, whereas,
NR5 receptors, labeled in
green, act only as monomers,
and NR6, in brown,
only form homodimers,
according to current
understanding.
The three RXRs, labeled in
light blue in the middle,
are the universal
heterodimer partner for
other nuclear receptors,
and the NR0 receptors,
DAX1 and SHP, on
the upper right lack a DNA
binding domain as we have seen,
so they are not included in
the classification according
to DNA interaction type.